Patents by Inventor Gabriel GAMBER

Gabriel GAMBER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11420933
    Abstract: This invention provides for a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1-R4, L1, n and p are defined herein. The compounds of formula (X) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: August 23, 2022
    Assignee: Novartis AG
    Inventors: Luis Brito, Delai Chen, Gabriel Gamber, Andrew Geall, Kevin Love, Thomas Zabawa, Frederic Zecri
  • Publication number: 20210078936
    Abstract: This invention provides for a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1-R4, L1, n and p are defined herein. The compounds of formula (X) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.
    Type: Application
    Filed: November 25, 2020
    Publication date: March 18, 2021
    Inventors: Luis BRITO, Delai CHEN, Gabriel GAMBER, Andrew GEALL, Kevin LOVE, Thomas ZABAWA, Frederic ZECRI